BIOACTOR and PIXIENCE start collaboration on validation of skin imaging technology in nutrition studies
Press release
BIOACTOR and PIXIENCE announce the start of a collaboration to test and validate an innovative skin imaging and testing technology in the context of a clinical study with a nutritional bioactive.
BIOACTOR and PIXIENCE announce the start of a collaboration to test and validate an innovative skin imaging and testing technology in the context of a clinical study with a nutritional bioactive.
PIXIENCE has developed an innovative skin image capturing device (C-Cube) and image analysis software (QuickScale) for the evaluation of several skin parameters, including the evaluation of 3D images.
BIOACTOR has expertise in the clinical validation of health effects of natural compounds and is now setting-up a clinical testing platform around nutritional actives for skin health.
PIXIENCE is developing the C-Cube Clinical Edition and BIOACTOR will carry-out beta testing of the Clinical Edition in a new clinical study on an oral nutritional product. PIXIENCE will provide technical assistance to BIOACTOR for the skin image analysis in this new clinical study.
Sebastien Mangeruca, CEO of PIXIENCE comments:
“We have initially developed our C-Cube and QuickScale suite of technologies for the evaluation of topical cosmetic products. BIOACTOR’s experience in running clinical studies for nutrition and its active programme around nutrition and skin health, makes them an ideal partner for testing and validating of our C-Cube Clinical Edition for nutrition studies”.
Hans van der Saag, CEO of BIOACTOR comments:
“BIOACTOR is delighted to work with PIXIENCE, as PIXIENCE has developed a best in class skin imaging and analysis technology that will allow us to further improve our skin health for nutrition platform. BIOACTOR wants to bring clinically backed innovation to the nutrition industry. BIOACTOR tests all of its products in scientifically robust human intervention studies, working with partners like PIXIENCE and the Department of Health and Nutrition of Maastricht University.”
About BIOACTOR
BIOACTOR, based in Maastricht, Netherlands, is a product development company that develops and supplies proprietary bioactive formulations to the health and sports nutrition industry. All BIOACTOR’s products are clinically tested, doping-free and from natural origin. The main focus areas are: gut microbiome, brain health, energy & vitality and skin health.
For more information, please contact:
BioActor
Hans van der Saag, CEO
Email: hans.vandersaag@bioactor.com
Pixience
Sébastien Mangeruca, CEO
Email: Sebastien.mangeruca@pixience.com
www.pixience.com
